IL-33 and IL-4Ra blockade impact distinct and overlapping inflammatory mediators of airway disease
S. Asrat (Tarrytown, United States), G. Scott (Tarrytown, United States), J. Allinne (Tarrytown, United States), W. Lim (Tarrytown, United States), D. Birchard (Tarrytown, United States), L. Ben (Tarrytown, United States), A. Murphy (Tarrytown, United States), M. Sleeman (Tarrytown, United States), J. Orengo (Tarrytown, United States), A. Le Floch (Tarrytown, United States), K. Nagashima (Tarrytown, United States), S. Srivatsan (Tarrytown, United States)
Source: International Congress 2022 – Respiratory inflammation and the pulmonary consequences of COVID-19
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Asrat (Tarrytown, United States), G. Scott (Tarrytown, United States), J. Allinne (Tarrytown, United States), W. Lim (Tarrytown, United States), D. Birchard (Tarrytown, United States), L. Ben (Tarrytown, United States), A. Murphy (Tarrytown, United States), M. Sleeman (Tarrytown, United States), J. Orengo (Tarrytown, United States), A. Le Floch (Tarrytown, United States), K. Nagashima (Tarrytown, United States), S. Srivatsan (Tarrytown, United States). IL-33 and IL-4Ra blockade impact distinct and overlapping inflammatory mediators of airway disease. 4268
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|